SCHEMBL5220262

SCHEMBL5220262

Cn1cc(C(=O)c2cnc[nH]2)cc1C(=O)c1ccc(Cl)cc1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 1/20 0.47
CYP2C9 P11712 3/20 0.43
KMT2A Q03164 3/20 0.43
MEN1 O00255 1/20 0.43
POLB P06746 1/20 0.43
HTT P42858 3/20 0.43
CYP1A2 P05177 3/20 0.41
CYP2C19 P33261 3/20 0.41
HDAC3 O15379 1/20 0.41
HDAC4 P56524 1/20 0.41
HDAC1 Q13547 1/20 0.41
HDAC7 Q8WUI4 1/20 0.41
HDAC2 Q92769 1/20 0.41
HDAC10 Q969S8 1/20 0.41
HDAC11 Q96DB2 1/20 0.41
HDAC8 Q9BY41 1/20 0.41
HDAC6 Q9UBN7 1/20 0.41
HDAC9 Q9UKV0 1/20 0.41
HDAC5 Q9UQL6 1/20 0.41
SMN1; SMN2 Q16637 3/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7507358 0.83 GAA (0.55) GAAKMT2AMEN1HTTSMN1; SMN2
SCHEMBL5216771 0.79 HTT (0.52) CYP2C9KMT2AMEN1POLBHTT
SCHEMBL10944422 0.76 CYP2C9 (0.57) CYP2C9KMT2AMEN1POLBHTT
Hydrochloric Acid SCHEMBL5307392 0.75 HTT (0.45) GAACYP2C9KMT2AMEN1POLB
SCHEMBL6954324 0.72 GSK3B (0.54) CYP2C9KMT2AMEN1POLBHTT
SCHEMBL27001673 0.71 GAA (0.59) GAAKMT2AHTTSMN1; SMN2LMNA
SCHEMBL5220586 0.71 CYP2C9 (0.39) GAACYP2C9KMT2AMEN1POLB
Hydrochloric Acid SCHEMBL6955433 0.70 CYP2C9 (0.45) CYP2C9KMT2AMEN1POLBHTT
SCHEMBL6318951 0.70 CYP2C9 (0.50) CYP2C9KMT2AMEN1POLBHTT
SCHEMBL10936785 0.69 NPSR1 (0.47) CYP2C9KMT2AMEN1POLBHTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1458386-B1 AROYL PYRROLE HETEROERYL AND METHANOLS USEFUL FOR TREATING A CENTRAL NERVOUS SYSTEM DISORDER ORTHO MCNEIL PHARM INC (US) 2007-04-18 EP disclosed
US-20050148636-A1 Useful aroyl pyrrole heteroaryl methanones and methanols JANSSEN PHARMACEUTICA, N.V. (BE) 2005-07-07 US disclosed
US-6897319-B2 Useful aroyl pyrrole heteroaryl methanones and methanols ORTHO-MCNEIL PHARMACEUTICAL, INC. (US) 2005-05-24 US disclosed
US-20040058980-A1 Useful aroyl pyrrole heteroaryl methanones and methanols ORTHO-MCNEIL PHARMACEUTICALS, INC. 2004-03-25 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050148636-A1 Useful aroyl pyrrole heteroaryl methanones and methanols CYP11B2, NLN, CNR2 GAA 2664/4885CYP2C9 521/4885KMT2A 2816/4885
US-20040058980-A1 Useful aroyl pyrrole heteroaryl methanones and methanols CYP11B2, NLN, CNR2 GAA 2664/4885CYP2C9 521/4885KMT2A 2816/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.